Search results

Production of nuclear medicine generators has resumed, with all relevant quality control checks passed, and medicine to be distributed across Australia from Sunday 25th October 2020.

With all excavation completed and rock removed from the underground site, the physics lab will now be built within the caverns of the Stawell Mines site.

Congress marks watershed moment for nuclear medicine and ANSTO

Scientists from Monash, ANSTo and China have developed an ultra-thin membrane that could separate harmful ions from water or capture gases.

The Australian Neutron Beam Users Group (ANBUG) presented annual awards to accomplished neutron scientists at the combined ANSTO User Meeting - AUM2023 held in late November 2023.

ANSTO has just completed the largest coordinated safety and security review of the OPAL multi-purpose research reactor, as part of a new a world-leading approach to assessing performance

ANSTO may provide travel and accommodation support to successful grant applicants from AINSE member organisations. Travel funds granted are to be used solely to cover the majority of the cost to travel to Sydney.

The Platypus instrument can be used to study all-manner of surface-science and interface problems, particularly related to magnetic recording materials and for polymer coatings, biosensors and artificial biological membranes.

A groundbreaking international study has provided new insights into global fossil methane emissions, using innovative multi-isotopic atmospheric measurements.  

The User Advisory Committee (UAC) is an independent group that provides advice to ANSTO Australian Synchrotron (AS) senior management on issues from a user perspective.

The Australian Synchrotron has an on-site Guesthouse for users and AS guests.

Highlights of the Energy Materials Project.

Targeted research to improve knowledge of past and present climate and the evolution of landscape.

Under the Government Procurement (Judicial Review) Act 2019 (Cth) ANSTO will publish Public Interest Certificates (PICs) for the current financial year where appropriate.

Shift in the treatment of blood cancers taking place.